First human tests begin for new MS hope
NCT ID NCT07225517
Summary
This is a very early study to check the safety of a new drug called BIIB145, which is being developed for multiple sclerosis (MS). Researchers will give the drug to 104 healthy volunteers to see what side effects occur and how the body absorbs and processes it. The study will test single doses, multiple doses, and whether taking it with food makes a difference.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PPD Austin Clinic
RECRUITINGAustin, Texas, 78744, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.